Efficiency of topical imiquimod 5% cream in the management of chronic radiation dermatitis with multiple neoplasias.

Eur J Dermatol

Department of Dermatology, Skin Cancer Centre Charité, Charité University Hospital, Schumannstr. 20/21, 10117 Berlin, Germany.

Published: May 2006

The immune response modifier imiquimod 5% cream (Aldara) was locally applied to an extensive thoracic chronic radiation dermatitis for 2 weeks on a once daily basis. After moderate to severe irritative reactions with erythema and crusted erosions, areas cleared up within 4 weeks. The patient has now been in complete remission for 2 years.

Download full-text PDF

Source

Publication Analysis

Top Keywords

imiquimod cream
8
chronic radiation
8
radiation dermatitis
8
efficiency topical
4
topical imiquimod
4
cream management
4
management chronic
4
dermatitis multiple
4
multiple neoplasias
4
neoplasias immune
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!